Vigilance on New-Onset Atherosclerosis Following SARS-CoV-2 Infection
The pandemic of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has become a global challenge to public health. While its typical clinical manifestations are respiratory disorders, emerging evidence of cardiovascular complications indicates the adverse interaction between SARS-CoV-2 infec...
Saved in:
Published in | Frontiers in medicine Vol. 7; p. 629413 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
20.01.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The pandemic of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has become a global challenge to public health. While its typical clinical manifestations are respiratory disorders, emerging evidence of cardiovascular complications indicates the adverse interaction between SARS-CoV-2 infection and cardiovascular outcomes. Given that viral infection has emerged as an additional risk factor for atherosclerosis, in this paper, we attempt to clarify the susceptibility to new-onset atherosclerosis in individuals infected with SARS-CoV-2. Mechanistically, serving as functional receptors for SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2) mediates SARS-CoV-2 infection of endothelial cells (ECs) directly, leading to endothelial dysfunction and dysregulation of the renin-angiotensin system (RAS). In addition, high expression of CD147, an alternative receptor, and activation of the NLRP3 inflammasome may also contribute to atherosclerosis in the context of COVID-19. More importantly, SARS-CoV-2 attacks the immune system, which results in excessive inflammation and perpetuates a vicious cycle of deteriorated endothelial dysfunction that further promotes inflammation. The alterations in the blood lipid profile induced by COVID-19 should not be ignored in assessing the predisposition toward atherosclerosis in victims of COVID-19. A better understanding of the underlying mechanisms of SARS-CoV-2 infection and the long-term monitoring of inflammatory factors and endothelial function should be considered in the follow-up of patients who have recovered from COVID-19 for early detection and prevention of atherosclerosis. |
---|---|
AbstractList | The pandemic of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has become a global challenge to public health. While its typical clinical manifestations are respiratory disorders, emerging evidence of cardiovascular complications indicates the adverse interaction between SARS-CoV-2 infection and cardiovascular outcomes. Given that viral infection has emerged as an additional risk factor for atherosclerosis, in this paper, we attempt to clarify the susceptibility to new-onset atherosclerosis in individuals infected with SARS-CoV-2. Mechanistically, serving as functional receptors for SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2) mediates SARS-CoV-2 infection of endothelial cells (ECs) directly, leading to endothelial dysfunction and dysregulation of the renin-angiotensin system (RAS). In addition, high expression of CD147, an alternative receptor, and activation of the NLRP3 inflammasome may also contribute to atherosclerosis in the context of COVID-19. More importantly, SARS-CoV-2 attacks the immune system, which results in excessive inflammation and perpetuates a vicious cycle of deteriorated endothelial dysfunction that further promotes inflammation. The alterations in the blood lipid profile induced by COVID-19 should not be ignored in assessing the predisposition toward atherosclerosis in victims of COVID-19. A better understanding of the underlying mechanisms of SARS-CoV-2 infection and the long-term monitoring of inflammatory factors and endothelial function should be considered in the follow-up of patients who have recovered from COVID-19 for early detection and prevention of atherosclerosis. |
Author | Zhang, Hai-Gang Liu, Ya |
AuthorAffiliation | Department of Pharmacology, College of Pharmacy, Army Medical University (Third Military Medical University) , Chongqing , China |
AuthorAffiliation_xml | – name: Department of Pharmacology, College of Pharmacy, Army Medical University (Third Military Medical University) , Chongqing , China |
Author_xml | – sequence: 1 givenname: Ya surname: Liu fullname: Liu, Ya organization: Department of Pharmacology, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China – sequence: 2 givenname: Hai-Gang surname: Zhang fullname: Zhang, Hai-Gang organization: Department of Pharmacology, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33553222$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkUtP3DAUha2KqjzKvqsqy24yta_jRzaVRiMoI6EiAUXdWY5zPRhlbBpnQP33eBiKYGNb9rmfj845JHsxRSTkC6MzznX73a-xnwEFOpPQNox_IAcAray10H_23pz3yXHOd5RSxkEU3Seyz7kQHAAOyMlNWIXBRodVitUvfKwvYsapmk-3OKbshu0acnWahiE9hriqruaXV_Ui3dRQLaNHN4UUP5OP3g4Zj1_2I_L79OR6cVafX_xcLubntWskTDUq3upeO89a6azw3iknsNdcSekVdrZR3INsPfXKyg64ZlJoy1FCh4wKfkSWO26f7J25H8Pajv9MssE8X6RxZew4heLaQMOVotr2nW6azmnrOt43koLTAE75wvqxY91vupKkwziNdngHff8Sw61ZpQejtBBC0wL49gIY098N5smsQ3Y4lDQxbXJxoFXDgTNWpHQndSXNPKJ__YZRsy3TbMs02zLNrswy8vWtvdeB_9XxJ34nnLQ |
CitedBy_id | crossref_primary_10_3389_fragi_2024_1426436 crossref_primary_10_3389_fmicb_2022_1042200 crossref_primary_10_1177_21501319211070685 crossref_primary_10_1016_j_compbiomed_2021_104459 crossref_primary_10_1089_vim_2022_0139 crossref_primary_10_1016_j_cellsig_2023_110909 crossref_primary_10_22159_ijap_2024v16i2_50128 crossref_primary_10_1016_j_pcad_2024_02_005 crossref_primary_10_1152_japplphysiol_00793_2021 crossref_primary_10_1186_s12872_023_03137_7 crossref_primary_10_3389_fcvm_2022_981023 crossref_primary_10_1038_s41401_022_00998_0 crossref_primary_10_3389_fmed_2022_809033 crossref_primary_10_1186_s12879_024_09374_1 crossref_primary_10_2147_JIR_S344730 crossref_primary_10_3389_fnut_2022_1007816 crossref_primary_10_36660_ijcs_20220208 crossref_primary_10_1111_jch_14259 crossref_primary_10_2147_IMCRJ_S385264 crossref_primary_10_3390_cells12050707 crossref_primary_10_24075_brsmu_2021_026 crossref_primary_10_3390_diagnostics13030478 |
Cites_doi | 10.1016/j.virol.2015.08.010 10.3899/jrheum.080324 10.1016/S0140-6736(20)30937-5 10.1016/j.autrev.2010.07.016 10.1093/jb/mvv127 10.1038/s41577-020-0308-3 10.1016/j.atherosclerosis.2012.01.051 10.1161/01.CIR.0000131515.03336.f8 10.1016/j.jstrokecerebrovasdis.2020.104984 10.1038/nrrheum.2015.40 10.1016/j.jacl.2020.04.008 10.1097/QAD.0b013e32835eca9b 10.1084/jem.148.1.335 10.1097/QAD.0b013e328333ea9e 10.1016/j.jvsv.2020.06.006 10.1016/S0140-6736(20)30183-5 10.1016/j.jvs.2020.04.483 10.4103/jisp.jisp_205_17 10.1016/j.tcm.2019.01.004 10.1161/CIRCRESAHA.120.317242 10.1038/ni.1861 10.1007/s12026-016-8873-z 10.1016/S0167-0115(00)00178-6 10.1111/all.14429 10.1007/s12265-015-9608-6 10.1093/cvr/cvt245 10.1038/s41569-020-0360-5 10.3389/fcvm.2016.00030 10.3390/jcm9051417 10.1038/s41586-020-2012-7 10.1016/S0002-9149(01)01539-9 10.1101/2020.03.27.20045427 10.1007/BF00809573 10.1016/j.jmii.2020.03.022 10.1093/infdis/jiaa528 10.1002/rth2.12414 10.3389/fcvm.2018.00185 10.1056/NEJMoa0810787 10.1093/cid/ciy168 10.1161/ATVBAHA.113.301320 10.1016/j.berh.2017.09.012 10.1185/030079904X4185 10.1038/s41598-017-09536-z 10.1097/CM9.0000000000000722 10.1007/s00011-015-0805-1 10.1016/j.thromres.2020.04.024 10.1093/cvr/cvy191 10.1186/1471-2458-10-706 10.1126/science.abb2507 10.1038/s41392-020-00426-x 10.3892/etm.2017.4062 10.1161/ATVBAHA.108.164715 10.1038/s41591-020-1021-2 10.1126/science.822515 10.1291/hypres.31.553 10.1016/j.cell.2020.04.004 10.1155/2016/2630865 10.1038/nm1267 10.1016/S0140-6736(20)31103-X 10.1101/2020.06.29.20140376 10.1161/CIRCRESAHA.118.311362 10.3851/IMP2724 10.1161/STROKEAHA.120.031265 10.1093/qjmed/hcy305 10.1002/ejhf.1924 10.3389/fmicb.2019.00050 10.1016/j.atherosclerosis.2005.05.001 10.1016/j.cmet.2020.06.015 10.1056/NEJMoa2002032 10.1101/2020.03.21.20040691 10.1016/j.tim.2014.09.007 10.1161/CIRCULATIONAHA.104.510461 10.1111/j.1440-1843.2011.01960.x 10.1007/s00134-020-06062-x 10.5603/KP.a2017.0165 10.1111/jth.14850 10.1128/JVI.01244-13 10.3389/fimmu.2020.00827 10.3389/fimmu.2020.01580 10.1016/j.cell.2020.02.052 10.7326/M13-1754 10.1097/MCA.0000000000000303 10.1016/S0140-6736(20)31094-1 10.1371/journal.ppat.1002857 10.1038/nature10146 10.1016/S1386-6532(99)00064-5 10.1016/S0140-6736(20)30566-3 10.1586/14779072.6.3.369 10.1016/j.cca.2020.07.015 10.1056/NEJMoa030781 10.1016/j.jep.2011.08.066 10.1016/j.arcmed.2015.05.006 10.1248/bpb.33.1324 10.1016/j.antiviral.2004.10.001 10.1182/blood.2020006000 10.1038/s41577-020-0321-6 10.1056/NEJMoa1707914 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Liu and Zhang. Copyright © 2021 Liu and Zhang. 2021 Liu and Zhang |
Copyright_xml | – notice: Copyright © 2021 Liu and Zhang. – notice: Copyright © 2021 Liu and Zhang. 2021 Liu and Zhang |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fmed.2020.629413 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2296-858X |
EndPage | 629413 |
ExternalDocumentID | oai_doaj_org_article_2437708adb844bc8acb3d4602c822c7f 10_3389_fmed_2020_629413 33553222 |
Genre | Journal Article Review |
GroupedDBID | 53G 5VS 9T4 AAFWJ ACGFS ACXDI ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK GROUPED_DOAJ HYE IAO IEA IHR IHW IPNFZ ISR KQ8 M48 M~E NPM OK1 PGMZT RIG RPM AAYXX AFPKN CITATION 7X8 ITC 5PM |
ID | FETCH-LOGICAL-c462t-e7398d8cf196ca5ffc7c5ed83766f7eba473f269f0f7a6b2381658a3e62be1053 |
IEDL.DBID | RPM |
ISSN | 2296-858X |
IngestDate | Fri Oct 04 13:12:38 EDT 2024 Tue Sep 17 21:15:11 EDT 2024 Sat Aug 17 05:40:06 EDT 2024 Thu Sep 26 18:11:32 EDT 2024 Tue Oct 15 08:55:29 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | COVID-19 atherosclerosis SARS-CoV-2 angiotensin-converting enzyme 2 inflammation endothelial dysfunction |
Language | English |
License | Copyright © 2021 Liu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-e7398d8cf196ca5ffc7c5ed83766f7eba473f269f0f7a6b2381658a3e62be1053 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 This article was submitted to Infectious Diseases - Surveillance, Prevention and Treatment, a section of the journal Frontiers in Medicine Reviewed by: Aris P. Agouridis, German Oncology Center, Cyprus; Pedro Xavier-Elsas, Federal University of Rio de Janeiro, Brazil Edited by: Constantinos Tsioutis, European University Cyprus, Cyprus |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855580/ |
PMID | 33553222 |
PQID | 2487432311 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_2437708adb844bc8acb3d4602c822c7f pubmedcentral_primary_oai_pubmedcentral_nih_gov_7855580 proquest_miscellaneous_2487432311 crossref_primary_10_3389_fmed_2020_629413 pubmed_primary_33553222 |
PublicationCentury | 2000 |
PublicationDate | 2021-01-20 |
PublicationDateYYYYMMDD | 2021-01-20 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in medicine |
PublicationTitleAlternate | Front Med (Lausanne) |
PublicationYear | 2021 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Davignon (B35) 2004; 109 Zhou (B73) 2020; 395 Tan (B63) 2005; 65 Zhang (B58) 2020; 32 Zheng (B2) 2020; 17 Schmidt-Ott (B42) 2000; 93 Hoffmann (B24) 2020; 181 Liu (B83) 2010; 33 Sardu (B26) 2020; 9 Chen (B66) 2019; 10 Liang (B57) 2017; 13 Wrapp (B25) 2020; 367 Priyanka (B19) 2017; 21 Dogra (B81) 2020; 29 Kuba (B46) 2005; 11 Muramatsu (B52) 2016; 159 Ramlall (B74) 2020; 26 Yang (B41) 2013; 33 Yamanashi (B15) 2018; 67 Lo (B11) 2010; 24 Lachmann (B87) 2009; 360 Post (B12) 2014; 160 de Boer (B17) 2006; 184 Ichinohe (B60) 2010; 11 Shah (B22) 2019; 29 Igase (B47) 2008; 31 van den Berg (B69) 2020; 11 Ferrario (B48) 2005; 111 Gillis (B94) 2014; 19 Iwasaki (B65) 2020; 20 Guervilly (B27) 2020; 222 Horváth (B16) 2000; 16 Amvros'eva (B92) 1992; 114 Verdoni (B33) 2020; 395 Monteil (B29) 2020; 181 Wei (B90) 2020; 14 Connors (B77) 2020; 135 Wu (B18) 2016; 2016 Diao (B72) 2020; 11 Wang (B51) 2020; 5 Campbell (B37) 2015; 46 Chen (B64) 2015; 23 Huang (B1) 2020; 395 Kow (B80) 2020; 8 Anand (B36) 2018; 5 Ziegler (B95) 2019; 115 Motomura (B93) 2008; 35 Weiss (B43) 2001; 87 CG (B5) 2018; 76 Nieto-Torres (B62) 2015; 485 Ksiazek (B7) 2003; 348 Zhang (B50) 2020; 126 Croca (B86) 2017; 31 Peretz (B6) 2019; 112 Shrivastava (B59) 2016; 64 Hu (B89) 2020; 510 Guan (B3) 2020; 382 Cao (B68) 2020; 20 Ridker (B88) 2017; 377 Ito (B61) 2012; 8 Bian (B54) 2020 Radzikowska (B55) 2020; 75 Helms (B75) 2020; 46 Yuan (B84) 2011; 138 Panigada (B30) 2020; 18 Wu (B91) 2017; 7 Nazmi (B21) 2010; 10 Darabian (B45) 2015; 26 Zanni (B13) 2013; 27 Libby (B10) 2011; 473 Varga (B28) 2020; 395 Adinolfi (B14) 2012; 221 Dong (B39) 2008; 28 Fabricant (B4) 1978; 14 Meizlish (B31) 2020 Ren (B9) 2020; 133 Grebe (B70) 2018; 122 Bertrand (B44) 2004; 20 Katz (B78) 2020; 51 Tannock (B96) 2008; 6 Zhou (B23) 2020; 579 Zhang (B40) 2015; 64 Lawson (B20) 2016; 3 de Groot (B8) 2013; 87 Mousavizadeh (B67) 2020 Wang (B56) 2015; 8 Ross (B97) 1976; 193 Riphagen (B32) 2020; 395 Rosovsky (B82) 2020; 4 Bean (B49) 2020; 22 Jouneau (B53) 2011; 16 Sahara (B38) 2014; 101 Bellosta (B79) 2020 Lodigiani (B76) 2020; 191 Sitia (B34) 2010; 9 Skeoch (B85) 2015; 11 Chen (B71) 2020 |
References_xml | – volume: 485 start-page: 330 year: 2015 ident: B62 article-title: Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome publication-title: Virology doi: 10.1016/j.virol.2015.08.010 contributor: fullname: Nieto-Torres – volume: 35 start-page: 2395 year: 2008 ident: B93 article-title: Dose effects of corticosteroids on the development of osteonecrosis in rabbits publication-title: J Rheumatol doi: 10.3899/jrheum.080324 contributor: fullname: Motomura – volume: 395 start-page: 1417 year: 2020 ident: B28 article-title: Endothelial cell infection and endotheliitis in COVID-19 publication-title: Lancet doi: 10.1016/S0140-6736(20)30937-5 contributor: fullname: Varga – volume: 9 start-page: 830 year: 2010 ident: B34 article-title: From endothelial dysfunction to atherosclerosis publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2010.07.016 contributor: fullname: Sitia – volume: 159 start-page: 481 year: 2016 ident: B52 article-title: Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners publication-title: J Biochem. doi: 10.1093/jb/mvv127 contributor: fullname: Muramatsu – volume: 20 start-page: 269 year: 2020 ident: B68 article-title: COVID-19: immunopathology and its implications for therapy publication-title: Nat Rev Immunol doi: 10.1038/s41577-020-0308-3 contributor: fullname: Cao – volume: 221 start-page: 496 year: 2012 ident: B14 article-title: Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2012.01.051 contributor: fullname: Adinolfi – volume: 109 start-page: III27 year: 2004 ident: B35 article-title: Role of endothelial dysfunction in atherosclerosis publication-title: Circulation. doi: 10.1161/01.CIR.0000131515.03336.f8 contributor: fullname: Davignon – volume: 29 start-page: 104984 year: 2020 ident: B81 article-title: Hemorrhagic stroke and anticoagulation in COVID-19 publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2020.104984 contributor: fullname: Dogra – volume: 11 start-page: 390 year: 2015 ident: B85 article-title: Atherosclerosis in rheumatoid arthritis: is it all about inflammation? publication-title: Nat Rev Rheumatol. doi: 10.1038/nrrheum.2015.40 contributor: fullname: Skeoch – volume: 14 start-page: 297 year: 2020 ident: B90 article-title: Hypolipidemia is associated with the severity of COVID-19 publication-title: J Clin Lipidol doi: 10.1016/j.jacl.2020.04.008 contributor: fullname: Wei – volume: 27 start-page: 1263 year: 2013 ident: B13 article-title: Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men publication-title: AIDS doi: 10.1097/QAD.0b013e32835eca9b contributor: fullname: Zanni – volume: 14 start-page: 335 year: 1978 ident: B4 article-title: Virus-induced atherosclerosis publication-title: J Exp Med. doi: 10.1084/jem.148.1.335 contributor: fullname: Fabricant – volume: 24 start-page: 243 year: 2010 ident: B11 article-title: Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men publication-title: AIDS doi: 10.1097/QAD.0b013e328333ea9e contributor: fullname: Lo – volume: 8 start-page: 900 year: 2020 ident: B80 article-title: Use of low-molecular-weight heparin in COVID-19 patients publication-title: J Vasc Surg Venous Lymphat Disord doi: 10.1016/j.jvsv.2020.06.006 contributor: fullname: Kow – volume: 395 start-page: 497 year: 2020 ident: B1 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet doi: 10.1016/S0140-6736(20)30183-5 contributor: fullname: Huang – start-page: 31080 year: 2020 ident: B79 article-title: Acute limb ischemia in patients with COVID-19 pneumonia publication-title: J Vasc Surg doi: 10.1016/j.jvs.2020.04.483 contributor: fullname: Bellosta – volume: 21 start-page: 456 year: 2017 ident: B19 article-title: Detection of cytomegalovirus, Epstein-Barr virus, and Torque Teno virus in subgingival and atheromatous plaques of cardiac patients with chronic periodontitis publication-title: J Indian Soc Periodontol doi: 10.4103/jisp.jisp_205_17 contributor: fullname: Priyanka – volume: 29 start-page: 468 year: 2019 ident: B22 article-title: Inflammation, infection and atherosclerosis publication-title: Trends Cardiovasc Med doi: 10.1016/j.tcm.2019.01.004 contributor: fullname: Shah – volume: 126 start-page: 1671 year: 2020 ident: B50 article-title: Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.120.317242 contributor: fullname: Zhang – volume: 11 start-page: 404 year: 2010 ident: B60 article-title: Influenza virus activates inflammasomes via its intracellular M2 ion channel publication-title: Nat Immunol doi: 10.1038/ni.1861 contributor: fullname: Ichinohe – volume: 64 start-page: 1101 year: 2016 ident: B59 article-title: Inflammasomes and its importance in viral infections publication-title: Immunol Res doi: 10.1007/s12026-016-8873-z contributor: fullname: Shrivastava – volume: 93 start-page: 65 year: 2000 ident: B42 article-title: The multiple actions of angiotensin II in atherosclerosis publication-title: Regul Pept doi: 10.1016/S0167-0115(00)00178-6 contributor: fullname: Schmidt-Ott – volume: 75 start-page: 2829 year: 2020 ident: B55 article-title: Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors publication-title: Allergy doi: 10.1111/all.14429 contributor: fullname: Radzikowska – volume: 8 start-page: 59 year: 2015 ident: B56 article-title: Function of CD147 in atherosclerosis and atherothrombosis publication-title: J Cardiovasc Transl Res doi: 10.1007/s12265-015-9608-6 contributor: fullname: Wang – volume: 101 start-page: 236 year: 2014 ident: B38 article-title: Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation publication-title: Cardiovasc Res. doi: 10.1093/cvr/cvt245 contributor: fullname: Sahara – volume: 17 start-page: 259 year: 2020 ident: B2 article-title: COVID-19 and the cardiovascular system publication-title: Nat Rev Cardiol doi: 10.1038/s41569-020-0360-5 contributor: fullname: Zheng – volume: 3 start-page: 30 year: 2016 ident: B20 article-title: Multiple infectious agents and the origins of atherosclerotic coronary artery disease publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2016.00030 contributor: fullname: Lawson – volume: 9 start-page: 1417 year: 2020 ident: B26 article-title: Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence publication-title: J Clin Med doi: 10.3390/jcm9051417 contributor: fullname: Sardu – volume: 579 start-page: 270 year: 2020 ident: B23 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: Nature doi: 10.1038/s41586-020-2012-7 contributor: fullname: Zhou – volume: 87 start-page: 25C year: 2001 ident: B43 article-title: Angiotensin II and atherosclerosis publication-title: Am J Cardiol doi: 10.1016/S0002-9149(01)01539-9 contributor: fullname: Weiss – year: 2020 ident: B71 article-title: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes publication-title: medRxiv doi: 10.1101/2020.03.27.20045427 contributor: fullname: Chen – volume: 114 start-page: 1338 year: 1992 ident: B92 article-title: Lipid metabolism in experimental virus infections publication-title: Bull Exp Biol Med. doi: 10.1007/BF00809573 contributor: fullname: Amvros'eva – year: 2020 ident: B67 article-title: Genotype and phenotype of COVID-19: their roles in pathogenesis publication-title: J Microbiol Immunol Infect doi: 10.1016/j.jmii.2020.03.022 contributor: fullname: Mousavizadeh – volume: 222 start-page: 1789 year: 2020 ident: B27 article-title: Circulating endothelial cells as a marker of endothelial injury in severe COVID−19 publication-title: J Infect Dis doi: 10.1093/infdis/jiaa528 contributor: fullname: Guervilly – volume: 4 start-page: 969 year: 2020 ident: B82 article-title: Anticoagulation practice patterns in COVID-19: a global survey publication-title: Res Pract Thromb Haemost doi: 10.1002/rth2.12414 contributor: fullname: Rosovsky – volume: 5 start-page: 185 year: 2018 ident: B36 article-title: HIV proteins and endothelial dysfunction: implications in cardiovascular disease publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2018.00185 contributor: fullname: Anand – volume: 360 start-page: 2416 year: 2009 ident: B87 article-title: Use of canakinumab in the cryopyrin-associated periodic syndrome publication-title: N Engl J Med doi: 10.1056/NEJMoa0810787 contributor: fullname: Lachmann – volume: 67 start-page: 291 year: 2018 ident: B15 article-title: Human T-cell leukemia virus-1 infection is associated with atherosclerosis as measured by carotid intima-media thickness in Japanese community-dwelling older People publication-title: Clin Infect Dis doi: 10.1093/cid/ciy168 contributor: fullname: Yamanashi – volume: 33 start-page: 1978 year: 2013 ident: B41 article-title: Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.113.301320 contributor: fullname: Yang – volume: 31 start-page: 364 year: 2017 ident: B86 article-title: Atherosclerosis in systemic lupus erythematosus publication-title: Best Pract Res Clin Rheumatol. doi: 10.1016/j.berh.2017.09.012 contributor: fullname: Croca – volume: 20 start-page: 1559 year: 2004 ident: B44 article-title: Provision of cardiovascular protection by ACE inhibitors: a review of recent trials publication-title: Curr Med Res Opin doi: 10.1185/030079904X4185 contributor: fullname: Bertrand – volume: 7 start-page: 9110 year: 2017 ident: B91 article-title: Altered lipid metabolism in recovered SARS patients twelve years after infection publication-title: Sci Rep doi: 10.1038/s41598-017-09536-z contributor: fullname: Wu – volume: 133 start-page: 1015 year: 2020 ident: B9 article-title: Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study publication-title: Chin Med J (Engl) doi: 10.1097/CM9.0000000000000722 contributor: fullname: Ren – volume: 64 start-page: 253 year: 2015 ident: B40 article-title: ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response publication-title: Inflamm Res doi: 10.1007/s00011-015-0805-1 contributor: fullname: Zhang – volume: 191 start-page: 9 year: 2020 ident: B76 article-title: Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy publication-title: Thromb Res doi: 10.1016/j.thromres.2020.04.024 contributor: fullname: Lodigiani – volume: 115 start-page: 213 year: 2019 ident: B95 article-title: Interleukin 6 trans-signalling and risk of future cardiovascular events publication-title: Cardiovasc Res doi: 10.1093/cvr/cvy191 contributor: fullname: Ziegler – volume: 10 start-page: 706 year: 2010 ident: B21 article-title: The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis publication-title: BMC Public Health. doi: 10.1186/1471-2458-10-706 contributor: fullname: Nazmi – volume: 367 start-page: 1260 year: 2020 ident: B25 article-title: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation publication-title: Science doi: 10.1126/science.abb2507 contributor: fullname: Wrapp – volume: 5 start-page: 283 year: 2020 ident: B51 article-title: CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-020-00426-x contributor: fullname: Wang – volume: 13 start-page: 835 year: 2017 ident: B57 article-title: Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway publication-title: Exp Ther Med doi: 10.3892/etm.2017.4062 contributor: fullname: Liang – volume: 28 start-page: 1270 year: 2008 ident: B39 article-title: Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis publication-title: Arterioscler Thromb Vasc Biol. doi: 10.1161/ATVBAHA.108.164715 contributor: fullname: Dong – volume: 26 start-page: 1609 year: 2020 ident: B74 article-title: Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection publication-title: Nat Med doi: 10.1038/s41591-020-1021-2 contributor: fullname: Ramlall – volume: 193 start-page: 1094 year: 1976 ident: B97 article-title: Hyperlipidemia and atherosclerosis publication-title: Science doi: 10.1126/science.822515 contributor: fullname: Ross – volume: 31 start-page: 553 year: 2008 ident: B47 article-title: Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade publication-title: Hypertens Res doi: 10.1291/hypres.31.553 contributor: fullname: Igase – volume: 181 start-page: 905 year: 2020 ident: B29 article-title: Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2 publication-title: Cell. doi: 10.1016/j.cell.2020.04.004 contributor: fullname: Monteil – volume: 2016 start-page: 2630865 year: 2016 ident: B18 article-title: Herpes simplex virus type 1 and type 2 infection increases atherosclerosis risk: evidence based on a meta-analysis publication-title: Biomed Res Int doi: 10.1155/2016/2630865 contributor: fullname: Wu – volume: 11 start-page: 875 year: 2005 ident: B46 article-title: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury publication-title: Nat Med doi: 10.1038/nm1267 contributor: fullname: Kuba – volume: 395 start-page: 1771 year: 2020 ident: B33 article-title: An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)31103-X contributor: fullname: Verdoni – year: 2020 ident: B31 article-title: Circulating markers of angiogenesis and endotheliopathy in COVID-19 publication-title: medRxiv doi: 10.1101/2020.06.29.20140376 contributor: fullname: Meizlish – volume: 122 start-page: 1722 year: 2018 ident: B70 article-title: NLRP3 inflammasome and the IL-1 pathway in atherosclerosis publication-title: Circ Res doi: 10.1161/CIRCRESAHA.118.311362 contributor: fullname: Grebe – volume: 19 start-page: 309 year: 2014 ident: B94 article-title: Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals publication-title: Antivir Ther. doi: 10.3851/IMP2724 contributor: fullname: Gillis – volume: 51 start-page: e227 year: 2020 ident: B78 article-title: Cerebrovascular complications of COVID-19 publication-title: Stroke doi: 10.1161/STROKEAHA.120.031265 contributor: fullname: Katz – volume: 112 start-page: 749 year: 2019 ident: B6 article-title: Influenza virus and atherosclerosis publication-title: QJM. doi: 10.1093/qjmed/hcy305 contributor: fullname: Peretz – volume: 22 start-page: 967 year: 2020 ident: B49 article-title: Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust publication-title: Eur J Heart Fail doi: 10.1002/ejhf.1924 contributor: fullname: Bean – volume: 10 start-page: 50 year: 2019 ident: B66 article-title: Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome publication-title: Front Microbiol doi: 10.3389/fmicb.2019.00050 contributor: fullname: Chen – volume: 184 start-page: 322 year: 2006 ident: B17 article-title: Epstein Barr virus specific T-cells generated from unstable human atherosclerotic lesions: implications for plaque inflammation publication-title: Atherosclerosis. doi: 10.1016/j.atherosclerosis.2005.05.001 contributor: fullname: de Boer – volume: 32 start-page: 176 year: 2020 ident: B58 article-title: In-Hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19 publication-title: Cell Metab doi: 10.1016/j.cmet.2020.06.015 contributor: fullname: Zhang – volume: 382 start-page: 1708 year: 2020 ident: B3 article-title: Clinical characteristics of coronavirus disease 2019 in China publication-title: N Engl J Med. doi: 10.1056/NEJMoa2002032 contributor: fullname: Guan – year: 2020 ident: B54 article-title: Meplazumab treats COVID-19 pneumonia: an open labelled, concurrent controlled add-on clinical trial publication-title: medRxiv doi: 10.1101/2020.03.21.20040691 contributor: fullname: Bian – volume: 23 start-page: 55 year: 2015 ident: B64 article-title: Response of host inflammasomes to viral infection publication-title: Trends Microbiol doi: 10.1016/j.tim.2014.09.007 contributor: fullname: Chen – volume: 111 start-page: 2605 year: 2005 ident: B48 article-title: Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 publication-title: Circulation. doi: 10.1161/CIRCULATIONAHA.104.510461 contributor: fullname: Ferrario – volume: 16 start-page: 705 year: 2011 ident: B53 article-title: EMMPRIN (CD147) regulation of MMP-9 in bronchial epithelial cells in COPD publication-title: Respirology doi: 10.1111/j.1440-1843.2011.01960.x contributor: fullname: Jouneau – volume: 46 start-page: 1089 year: 2020 ident: B75 article-title: High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study publication-title: Intensive Care Med doi: 10.1007/s00134-020-06062-x contributor: fullname: Helms – volume: 76 start-page: 119 year: 2018 ident: B5 article-title: The relationship between exposure to hepatitis B virus and increased atherosclerosis-associated morbidity-a meta-analysis publication-title: Kardiol Pol. doi: 10.5603/KP.a2017.0165 contributor: fullname: CG – volume: 18 start-page: 1738 year: 2020 ident: B30 article-title: Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis publication-title: J Thromb Haemost doi: 10.1111/jth.14850 contributor: fullname: Panigada – volume: 87 start-page: 7790 year: 2013 ident: B8 article-title: Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group publication-title: J Virol. doi: 10.1128/JVI.01244-13 contributor: fullname: de Groot – volume: 11 start-page: 827 year: 2020 ident: B72 article-title: Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) publication-title: Front Immunol. doi: 10.3389/fimmu.2020.00827 contributor: fullname: Diao – volume: 11 start-page: 1580 year: 2020 ident: B69 article-title: Severe COVID-19: NLRP3 inflammasome dysregulated publication-title: Front Immunol doi: 10.3389/fimmu.2020.01580 contributor: fullname: van den Berg – volume: 181 start-page: 271 year: 2020 ident: B24 article-title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor publication-title: Cell doi: 10.1016/j.cell.2020.02.052 contributor: fullname: Hoffmann – volume: 160 start-page: 458 year: 2014 ident: B12 article-title: Associations between HIV infection and subclinical coronary atherosclerosis publication-title: Ann Intern Med. doi: 10.7326/M13-1754 contributor: fullname: Post – volume: 26 start-page: 678 year: 2015 ident: B45 article-title: CAC score as a possible criterion for administration of angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers: the MultiEthnic Study of Atherosclerosis publication-title: Coron Artery Dis doi: 10.1097/MCA.0000000000000303 contributor: fullname: Darabian – volume: 395 start-page: 1607 year: 2020 ident: B32 article-title: Hyperinflammatory shock in children during COVID-19 pandemic publication-title: Lancet doi: 10.1016/S0140-6736(20)31094-1 contributor: fullname: Riphagen – volume: 8 start-page: e1002857 year: 2012 ident: B61 article-title: Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002857 contributor: fullname: Ito – volume: 473 start-page: 317 year: 2011 ident: B10 article-title: Progress and challenges in translating the biology of atherosclerosis publication-title: Nature doi: 10.1038/nature10146 contributor: fullname: Libby – volume: 16 start-page: 17 year: 2000 ident: B16 article-title: The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis publication-title: J Clin Virol. doi: 10.1016/S1386-6532(99)00064-5 contributor: fullname: Horváth – volume: 395 start-page: 1054 year: 2020 ident: B73 article-title: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)30566-3 contributor: fullname: Zhou – volume: 6 start-page: 369 year: 2008 ident: B96 article-title: Advances in the management of hyperlipidemia-induced atherosclerosis publication-title: Expert Rev Cardiovasc Ther doi: 10.1586/14779072.6.3.369 contributor: fullname: Tannock – volume: 510 start-page: 105 year: 2020 ident: B89 article-title: Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection publication-title: Clin Chim Acta doi: 10.1016/j.cca.2020.07.015 contributor: fullname: Hu – volume: 348 start-page: 1953 year: 2003 ident: B7 article-title: A novel coronavirus associated with severe acute respiratory syndrome publication-title: N Engl J Med doi: 10.1056/NEJMoa030781 contributor: fullname: Ksiazek – volume: 138 start-page: 150 year: 2011 ident: B84 article-title: Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation publication-title: J Ethnopharmacol. doi: 10.1016/j.jep.2011.08.066 contributor: fullname: Yuan – volume: 46 start-page: 339 year: 2015 ident: B37 article-title: Infection and atherosclerosis development publication-title: Arch Med Res doi: 10.1016/j.arcmed.2015.05.006 contributor: fullname: Campbell – volume: 33 start-page: 1238 year: 2010 ident: B83 article-title: Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits publication-title: Biol Pharm Bull. doi: 10.1248/bpb.33.1324 contributor: fullname: Liu – volume: 65 start-page: 69 year: 2005 ident: B63 article-title: Characterization of viral proteins encoded by the SARS-coronavirus genome publication-title: Antiviral Res doi: 10.1016/j.antiviral.2004.10.001 contributor: fullname: Tan – volume: 135 start-page: 2033 year: 2020 ident: B77 article-title: COVID-19 and its implications for thrombosis and anticoagulation publication-title: Blood doi: 10.1182/blood.2020006000 contributor: fullname: Connors – volume: 20 start-page: 339 year: 2020 ident: B65 article-title: The potential danger of suboptimal antibody responses in COVID-19 publication-title: Nat Rev Immunol doi: 10.1038/s41577-020-0321-6 contributor: fullname: Iwasaki – volume: 377 start-page: 1119 year: 2017 ident: B88 article-title: Antiinflammatory therapy with canakinumab for atherosclerotic disease publication-title: N Engl J Med doi: 10.1056/NEJMoa1707914 contributor: fullname: Ridker |
SSID | ssj0001325413 |
Score | 2.334105 |
SecondaryResourceType | review_article |
Snippet | The pandemic of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has become a global challenge to public health. While its typical clinical... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 629413 |
SubjectTerms | angiotensin-converting enzyme 2 atherosclerosis COVID-19 endothelial dysfunction inflammation Medicine SARS-CoV-2 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nj9MwELVQD4gLYvnasAsKEpc9GBzbtZ1jt2pVkAoS3Va9Rf5cKqEE0Vb8fWaStGoREhcuOSSxYr1ne95knBdC3pUiFDw6S1mwksrCBZhzIlHvjShUYiww_FB4_lnNlvLTerg--dUX7gnr7IE74D6gYZ5mxgZnpHTeWO9EkIpxD6HN69SuvsXwJJlq364ISHwK0dUlIQsrgaaIxqCcvVe8lIU4i0OtXf_fNOafWyVPYs_0CXnci8Z81HX2gjyI9VPycN6XxZ-RyWpzv_mO_OVNncO6Rb_U27jLR6jumi20geNmm0-B9OYXBKt8Mfq6oONmRXn-sd-OVT8ny-nkbjyj_f8RqJeK72jUojTB-ASzyNthSl77YQyQciqVNBAgAXWuysSStsphcAa9YUVU3EXQVeIFGdRNHS9JrnhwSlhhWEJJxY11zKWEZjpey2gycnNAq_rR2WBUkD4gshUiWyGyVYdsRm4RzuN9aGDdngBaq57W6l-0ZuTtgYwKBjxWMWwdm_0WWhpQPSBLi4y87Mg5PkqAesLSUUb0GW1nfTm_Um--taba2qDzGXv1Pzp_RR5x3PrCCliErslg93MfX4N22bk37TD9DWE37Dg priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBUlgZBLafrpJi0u5NKDgixpJe2hhG3IkhY2haYbcjP6TBaCnaw3pPn3mbG9abfsqRcfbA8282Y8byzpiZD9oQgFj85SFqyksnABck4k6r0RhUqMBYYLhSen6mQqv18MLv4sj-4d2Kxt7XA_qen8-uD37cMhJPwX7Dih3gICETU_OTtQfChxC9tNLoXEeJ_0ZL_94yKgGSpEN1a51nCbbAmovzj4sFKmWjX_dRT035mUf5Wm8QvyvOeU-agLgh3yLFYvydakHzV_RY7PZ5eza4Q3r6scPmv0R9XERT5C8lc3YAPHWZOPISbqe6hl-dno5xk9qs8pz7_1s7Wq12Q6Pv51dEL77ROol4ovaNRiaILxCZLM20FKXvtBDNCRKpU04CMBFK6GiSVtlcPaDXTEiqi4i0C7xBuyUdVVfEdyxYNTwgrDEjIubqxjLiXU2vFaRpORz0tvlTedSkYJ3QU6uUQnl-jksnNyRr6iO5_uQ33r9kQ9vyz7dClRJlEzY4MzUjpvrHciSMW4B0LjdcrIpyUYJeQDDnLYKtZ3DVgaIEXAWouMvO3AeXrUEtyM6BXYVt5l9Uo1u2o1t7VBYTT2_r8td8k2x-kwrIAP0x7ZWMzv4gfgMwv3sQ3TRzrA9GM priority: 102 providerName: Scholars Portal |
Title | Vigilance on New-Onset Atherosclerosis Following SARS-CoV-2 Infection |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33553222 https://search.proquest.com/docview/2487432311 https://pubmed.ncbi.nlm.nih.gov/PMC7855580 https://doaj.org/article/2437708adb844bc8acb3d4602c822c7f |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4BB8Sl6rvpA6VSLz1417G9tnPcrljRSttWpSBuke3YNBI4iF3E32ecB2KrnnrJIY4Vaz7b801m_AXgU8nrgnlrCK2NIKKwNa45HohzmhcyUFrTdFB49V0en4pv57PzHZiNZ2G6on1nm0m8vJrE5k9XW3l95aZjndj052qhdFKpotNd2FWcPwrRuw8rHGOegvcpSQzASkTIJ01QRieSldh0APsc3WzKMWx5o060_19M8--CyUceaPkUngzUMZ_3Q3wGOz4-h_3VkBx_AUdnzUVzmVDM25jj7kV-xLXf5PPE8do19sFrs86XCH17hy4rP5n_OiGL9oyw_OtQlBVfwuny6PfimAx_SSBOSLYhXvFS19oFXEvOzEJwys18jYGnlEEhDAJtz2QZaFBG2uSikXUY7iWzHtkVfwV7sY3-DeSS1VZywzUNiVgxbSy1ISRJHaeE1xl8Hq1VXfdiGBUGEcnIVTJylYxc9UbO4Esy58NzSca6u9HeXFQDmFVSQ1RUm9pqIazTxlleC0mZQ97iVMjg4whGhdM-5TJM9O3tGntq5D5ITosMXvfgPLxqBDcDtQXb1li2W3CmddLaw8x6-98938EBS1UvtMD95z3sbW5u_QekLRt72IX7eF0JfdhN2Xs4Xu55 |
link.rule.ids | 230,315,733,786,790,870,891,2115,24346,27955,27956,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb5wwEB6lqZTm0vSZ0vRBpV56gDU2GHPcrrLatNm0apJVbsg2doqSQJRlVam_vmMeUTbqpb1wwFgYPo_nG2b8AfAxY0VEjZIBKWQcxJEq0OaYDbQWLOKWkIK4jcLzIz47jb-cJWcbkAx7Ydqifa3KsLq8CqvyZ1tbeX2lR0Od2Oj7fJIKp1JFRg_gIdorTe4E6e2nFYZRT8S6pCSGYBliZJwqKCUhpxk2bcMWQ0frsgxr_qiV7f8b17xfMnnHB013YDGMvis9uQhXjQr173vCjv_8eE_gcc9K_XHX_BQ2TPUMtuZ93v057C_K8_LSTRC_rnxcGINv1dI0_tjRx3qJffBYLv0pzqr6F3pD_3j84ziY1IuA-gd9vVf1Ak6n-yeTWdD_gCHQMadNYFKWiUJoi2aqZWKtTnViCoxpObcpIhwjrJRnlthUcuW8PxIayQynyiBxYy9hs6or8wp8TgvFmWSCWMfZqJCKKGudWo9OYyM8-DTAkF93Ohs5xicOvdyhlzv08g49Dz47nG6vcwrZ7Yn65jzvX2TuhBZTImShRBwrLaRWrIg5oRopkU6tBx8GlHO0KJcmkZWpV0vsKZBWIe-NPNjtUL-91TBrPEjX5sPaWNZbEOVWtbtH9fV_93wPj2Yn88P88ODo6x5sU1dcQyJc5t7AZnOzMm-RHTXqXWsLfwDpcw61 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BkVa9UJ4l5RUkLhyy69hZ2zkuS1ctsKWitKq4RPGrRLTJqpsVEr-ecR7VbsWplxwSW4nzzdjfZCafAd6nzMTUqjwiJk-iJFYGfY65SGvJYu4IMcT_KDw_4genyefz8fnaVl9N0b5WxbC8vBqWxa-mtnJxpUd9ndjoeD4V0qtUkdHCuNF9eIA-S8VaoN58XmEY-cSsTUxiGJYiTtYrg1Iy5DTFS9swYLjY-kzDxprUSPf_j2_eLptcW4dmO_CzH0FbfvJ7uKrVUP-9Je54pyE-gocdOw0nbZPHcM-WT2Aw7_LvT2H_rLgoLr2hhFUZ4gQZfSuXtg4nnkZWS-yDx2IZztC6qj-4KoYnk-8n0bQ6i2h42NV9lc_gdLb_Y3oQdRsxRDrhtI6sYKk0Ujt0V52PndNCj63B2JZzJxDpBOGlPHXEiZwrzwKQ2OTMcqosEjj2HLbKqrQvIOTUKM5yJonz3I3KXBHlnFft0SKxMoAPPRTZotXbyDBO8QhmHsHMI5i1CAbw0WN1084rZTcnquuLrHuZmRdcFETmRskkUVrmWjGTcEI1UiMtXADveqQz9CyfLslLW62W2FMivUL-Gwew2yJ_c6vecgIQGzax8SybVxDpRr27Q3bvzj3fwuD40yz7enj05SVsU19jQ2Kc7V7BVn29sq-RJNXqTeMO_wBuyRE1 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vigilance+on+New-Onset+Atherosclerosis+Following+SARS-CoV-2+Infection&rft.jtitle=Frontiers+in+medicine&rft.au=Liu%2C+Ya&rft.au=Zhang%2C+Hai-Gang&rft.date=2021-01-20&rft.pub=Frontiers+Media+S.A&rft.eissn=2296-858X&rft.volume=7&rft_id=info:doi/10.3389%2Ffmed.2020.629413&rft_id=info%3Apmid%2F33553222&rft.externalDBID=PMC7855580 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-858X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-858X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-858X&client=summon |